Cognition

DMAE

Choline-like compound studied for memory and attention, but human evidence for cognitive benefits is weak and mixed.

DMAE

Choline-like compound studied for memory and attention, but human evidence for cognitive benefits is weak and mixed.

score

evidence

Caution

risk

Overview

Forms

Safety

Stack

Quick Take

Weak evidence for cognition; only worth trying as an experiment, not as a reliable nootropic.

DMAE (dimethylaminoethanol) is a choline-like compound found in trace amounts in some fish such as anchovies and sardines, and sold as a supplement. It may influence cholinergic signaling and phospholipid metabolism, but oral DMAE does not reliably raise brain choline or acetylcholine in humans. Small, older trials have explored memory, attention, and hyperactivity, with mixed and generally weak results. It mainly appeals to people who want to experiment with cholinergic nootropics despite limited evidence.

Proven Benefits

May improve memory

May support attention

May reduce hyperactivity

Protocol

Amount

100-300 mg

Frequency

Once daily

When

Morning or early afternoon; avoid late-day dosing because it may cause insomnia.

Onset Time

2-6 weeks, if at all; many users notice no clear effect.

Who Should Consider

Healthy adults curious about cholinergic nootropics

Older adults exploring mild cognitive support

How It Works

DMAE is structurally similar to choline and may modestly affect acetylcholine and phosphatidylcholine pathways. Oral supplementation appears to have inconsistent brain penetration, so any effect is likely small and indirect rather than a robust increase in central acetylcholine.

Updated Invalid Date